EUVIMEDEUVIMED entdecken
Open Access

Peptide-driven identification of TCRs reveals dynamics and phenotypes of CD4 T cells in tuberculosis

Rashmi Tippalagama iD, Raphael Trevizani, Leila Y Chihab, Ashu Chawla, Kai Fung, Jason Greenbaum iD, Kendall Kearns, Aruna D De Silva, Wathsala Gunasinghe, Judy Perera, Hansani Gunasekara, Darsha D Senevirathne und 5 weitere

The Journal of Immunology · 2026

DOI: 10.1093/jimmun/vkaf287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2026. Verfasst von Rashmi Tippalagama und 16 weiteren Autor:innen. Beteiligte Einrichtung: Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, United States. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, CD4-Positive T-Lymphocytes, Receptors, Antigen, T-Cell, Tuberculosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Science Foundation, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Assigning antigen specificity to T cell receptor (TCR) sequences is challenging due to the TCR repertoire’s diversity and the complexity of TCR-antigen recognition. We developed the peptide-driven identification of TCRs (PDI-TCR) assay that combines in vitro expansion of cells with peptide pools, bulk TCR sequencing, and statistical analysis to identify antigen-specific TCRs from human blood. A key feature of PDI-TCR is the ability to distinguish true antigen-specific TCR clonotypes from TCRs associated with unspecific bystander activation by comparing responses to nonoverlapping peptide pools. We applied PDI-TCR to tuberculosis (TB) patients, sampling blood at diagnosis and throughout treatment, and Mycobacterium tuberculosis (Mtb)–sensitized healthy individuals (IGRA+). We identified hundreds of Mtb-specific TCRs, as well as unspecific TCRs, and characterized their phenotype in each cohort by single-cell RNA sequencing ex vivo. Mtb-specific T cells were highly diverse, with short-lived effector phenotypes only present in TB at diagnosis, while memory phenotypes were maintained through treatment. In contrast, unspecific expanded T cells were more clonally restricted, had a cytotoxic phenotype, and were maintained throughout treatment. While the PDI-TCR parameters used in this study are specific to Mtb, the underlying approach is broadly applicable to the study of antigen-specific T cells and can be adapted as needed for other antigen systems. Thus, PDI-TCR is a powerful tool for identifying antigen-specific TCRs and enables direct ex vivo identification and monitoring of antigen-specific T cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisCD4-Positive T-LymphocytesReceptors, Antigen, T-CellTuberculosisPeptidesHumansPhenotypeFemaleAntigens, BacterialMaleAdultImmunologic Memory

Stichwörter der Autor:innen

T cell receptorsantigen-specific T cellssingle-cell sequencingtuberculosis

Substanzen

Receptors, Antigen, T-CellPeptidesAntigens, Bacterial

Autor:innen und Institutionen

  • Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, United States.
  • Oswaldo Cruz Foundation, Eusébio, Ceará, Brazil.
  • Bioinformatics Core, La Jolla Institute for Immunology, La Jolla, CA 92037, United States.
  • Faculty of Medicine, General Sir John Kotelawala Defense University, Ratmalana, Sri Lanka.
  • National Hospital for Respiratory Diseases, Welisara, Sri Lanka.
  • South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.

ORCID-Profile: Rashmi Tippalagama, Jason Greenbaum, Julie G Burel

Förderung

  • NIAID NIH HHS
  • National Science Foundation
  • NIH HHS
  • National Institutes of Health’s Human Immunology
  • National Institutes of Health

Zitieren

APA

Tippalagama, R., Trevizani, R., Chihab, L. Y., Chawla, A., Fung, K., Greenbaum, J., Kearns, K., De Silva, A. D., Gunasinghe, W., Perera, J., Gunasekara, H., Senevirathne, D. D., Scriba, T., Sette, A., Lindestam Arlehamn, C., Burel, J. G., & Peters, B. (2026). Peptide-driven identification of TCRs reveals dynamics and phenotypes of CD4 T cells in tuberculosis. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf287

Vancouver

Tippalagama R, Trevizani R, Chihab LY, Chawla A, Fung K, Greenbaum J, et al. Peptide-driven identification of TCRs reveals dynamics and phenotypes of CD4 T cells in tuberculosis. The Journal of Immunology. 2026. doi:10.1093/jimmun/vkaf287

BibTeX
@article{Tippalagama2026,
  author = {Tippalagama, Rashmi and Trevizani, Raphael and Chihab, Leila Y and Chawla, Ashu and Fung, Kai and Greenbaum, Jason and Kearns, Kendall and De Silva, Aruna D and Gunasinghe, Wathsala and Perera, Judy and Gunasekara, Hansani and Senevirathne, Darsha D and Scriba, Thomas and Sette, Alessandro and Lindestam Arlehamn, Cecilia and Burel, Julie G and Peters, Bjoern},
  title = {Peptide-driven identification of TCRs reveals dynamics and phenotypes of CD4 T cells in tuberculosis},
  journal = {The Journal of Immunology},
  year = {2026},
  doi = {10.1093/jimmun/vkaf287}
}
Kostenlos starten →